Business Leaders and Experts Urge for Smarter Planning in London November 7, 2025 London, 7 November 2025 – Business leaders, policymakers, and industry experts gathered last month at the Emmanuel Centre, Westminster “London – Opportunities and Obstacles for Growth,” organised by the Central London Alliance CIC. The event explored the challenges and opportunities shaping London’s economic future featuring six panel discussions delving into the key features of the [...]
Pensions, motorists and workers: The tax targets Rachel Reeves is eyeing up November 7, 2025 If there is one thing that is clear three weeks out from the Autumn Budget, it is that Chancellor Rachel Reeves will hike taxes. The Office for Budget Responsibility (OBR), which scores the economic impacts of the government’s policies and publishes forecasts on public finances, has been questioned for being over optimistic on measures such [...]
Sky in talks to buy ITV’s broadcasting arm for £1.6bn November 7, 2025 ITV has confirmed it is in early talks with Sky over the possible sale of its media and entertainment division, in a move that could reshape the UK television industry. In a statement to the market on Friday, ITV announced that it was in “preliminary discussions” regarding a potential sale of its broadcasting and streaming [...]
Prothena Reports Third Quarter 2025 Financial Results and Business Highlights November 6, 2025 Net cash used in operating and investing activities was $40.6 million and $140.4 million for the third quarter and first nine months of 2025, respectively; quarter-end cash and restricted cash position was $331.7 million Roche to initiate the Phase 3 PARAISO clinical trial evaluating prasinezumab, a potential first-in-class anti-alpha-synuclein antibody, for early-stage Parkinson's disease by end of 2025 Novo Nordisk initiated the Phase 3 CLEOPATTRA clinical trial evaluating coramitug, a potential first-in-class amyloid depleter, for ATTR amyloidosis with cardiomyopathy Novo Nordisk to present Phase 2 results for coramitug during a late-breaking session at the American Heart Association Scientific Sessions on November 10, 2025 Bristol Myers Squibb obtained Fast Track designation from the U.S. FDA for BMS-986446 (PRX005), an anti-MTBR-tau-targeting antibody, for the treatment of Alzheimer’s disease Prothena will convene an Extraordinary General Meeting on November 19, 2025 to obtain shareholder approval on a proposal reducing share capital to create distributable reserves to support a share redemption program to be conducted in 2026 if deemed appropriate Potential to earn up to $105 million in aggregate clinical milestone payments by end of 2026 related to the advancement of coramitug for ATTR amyloidosis with cardiomyopathy by Novo Nordisk and PRX019 for neurodegenerative diseases by Bristol Myers Squibb
From insights to impact, Leinster Rugby leverages data strategy to level up fan experience November 6, 2025 BearingPoint supports the club in creating a roadmap for personalized experiences and future-ready innovation.
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights November 6, 2025 SANRECO Phase 2 study of divesiran in polycythemia vera (PV) fully enrolled; topline results anticipated in 3Q 2026 Strong balance sheet and cash runway into 2028
Reimagining 50 Fenchurch Street: A Sustainable Tower Rooted in the City’s Heritage November 6, 2025 The new development at 50 Fenchurch Street will deliver a 36-fold increase in public space on the ground floor level, with a public roof garden at the 10th floor level, while also providing 60,000 sq m of office space across 35 floors and 800 sq m of retail space. The plans also make provision for the Lambe’s Chapel [...]
Banks set to escape tax raid from Rachel Reeves after lobbying November 6, 2025 Rachel Reeves is expected to avoid a cash grab on Britain’s banking titans in her forthcoming autumn Budget after the industry flagged concerns around international competitiveness. The Chancellor is understood to be hesitant on targeting the banks for a cash raid after a string of warnings from top industry chiefs on the impact on economic [...]
TITAN Group: Nine-Month 2025 Results November 6, 2025 Regulatory News: Titan SA (Euronext Brussels, ATHEX and Euronext Paris, TITC) announces the nine-month 2025 financial results. Record nine-month EBITDA profitability and a positive outlook Group Sales YTD increased by 1.4%, at €2,013m, thanks to the strong performance in Greece, in the US & in Egypt, driven by increased volumes and overall firm pricing levels. [...]
PostFinance Strengthens Fraud Protection and Customer Communications with FICO Technology November 6, 2025 Swiss digital banking leader uses FICO® Falcon® Fraud Manager for debit cards, adds FICO® Customer Communication Services for 24/7 support